Status: Recruiting
Acetazolamide for Treatment Resistant Schizophrenia
This is a double blind adjunctive randomized controlled trial for schizophrenia using acetazolamide.
Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18-55Biological sex: AllType: InterventionalSponsor: Vishwajit Nimgaonkar, MD PhDUpdated: Apr 7, 2026Locations: 2
Eligibility criteria
Written informed consent. [+4]
Substance abuse in the past month/dependence past 6 months with the exception of... [+5]